What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Relypsa: Unglamorous Niche, Exciting Opportunity
- View all 1 replies
IndyPEG + Follow Following - Unfollow | Send Message 8 Jun: I like itJun 8, 2:23 PM
Relypsa, Inc. operates as a bio-pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed for the treatment of... More
Country: United States
at Benzinga (Jun 16, 2016)
at Investopedia (Jun 13, 2016)
at Benzinga (Jun 9, 2016)
Morgan Stanley Downgrades Relypsa, Expects Focus To Return To The Challenged Veltassa Launch & Cash Burnat Benzinga (Jun 7, 2016)
at Zacks.com (May 30, 2016)
Other News & PR